-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

The Microbiome and Graft Versus Host Disease

Program: Special Scientific Symposia
Session: Friend or Foe: The Microbiome, Antibiotics and Death After Transplant
Sunday, December 6, 2020, 9:25 AM-9:30 AM

Marcel van den Brink, MD, PhD

Memorial Sloan- Kettering Cancer Center, New York, NY

Disclosures: van den Brink: DKMS: Other; Juno: Patents & Royalties; WindMIL Therapeutics: Honoraria; Magenta Therapeutics: Honoraria; Merck & Co, Inc.: Honoraria; Amgen: Honoraria; Therakos: Honoraria; Jazz Pharmaceuticals: Honoraria; Evelo: Honoraria; Seres Therapeutics: Current equity holder in private company, Honoraria, Patents & Royalties, Research Funding.